Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 47 - ALCOHOL AND DRUG ABUSE ADMINISTRATION › Chapter 10.47.01 - Requirements › Section 10.47.01.02 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  subtitle, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Addiction Severity Index" means a
				  standardized method for the assessment of adults regarding addictions severity
				  and patient need.
(2)
				  "Administration" means the Alcohol and Drug Abuse Administration within the
				  Department of Health and Mental Hygiene.
(3) "Administrator" means the program
				  director of an alcohol or drug abuse facility or a health care
				  facility.
(4) "Admission" means the
				  documented acceptance of an applicant into a program.
(5) "Adolescent" means an individual 12-17
				  years old.
(6) "Alcohol abuse"
				  means a disease that is characterized by a pattern of pathological use of
				  alcohol with repeated attempts to control its use, and with significant
				  negative consequences in at least one of the following areas of life: medical,
				  legal, financial, or psychosocial.
(7) "Alcohol dependence" means a disease
				  characterized by:
(a) Alcohol abuse;
				  and
(b) Physical symptoms of
				  withdrawal or tolerance.
(8) "American Society of Addiction Medicine
				  Patient Placement Criteria" means an instrument designed to indicate patient
				  placement guidelines for admission, continued stay, and discharge.
(9) "Assessment" means the process of
				  ascertaining the treatment needs of the patient regarding addiction and other
				  social issues.
(10) "Caseload"
				  means the number of patients for whom a drug and alcohol counselor has the
				  responsibility for providing clinical services and case management.
(11) "Case management" means the process of
				  coordinating and monitoring the services provided to a patient both within the
				  program and in conjunction with other providers.
(12) "Certification" means the approval
				  issued to a program by the Administration to provide services under this
				  subtitle.
(13) "Child" means an
				  individual younger than 12 years old.
(14) "Clinical director" means the individual
				  who is responsible for the therapeutic and rehabilitative aspects and direction
				  of a program.
(15) "Clinical staff"
				  means the individuals employed by or associated with a program who provide
				  treatment, care, or rehabilitation to program patients or patients'
				  families.
(16) "Clinical
				  supervisor" means the individual responsible for providing supervision to
				  alcohol and drug clinical staff as clinically appropriate.
(17) "Continuous quality review" means
				  objective and systematic monitoring and evaluation of the quality and
				  appropriateness of patient care, the purpose of which is the improvement of
				  that care, prevention of problems, and resolution of problems.
(18) "Controlled dangerous substance" means
				  any drug, substance, or immediate precursor in Schedules I-V under Criminal Law
				  Article, Title 5, Subtitle 4, Annotated Code of Maryland.
(19) Correctional Facility.
(a) "Correctional facility" means an
				  institution overseen by the State or one of the 24 subdivisions where
				  individuals are incarcerated.
(b)
				  "Correctional facility" includes a jail, detention center, prison, or
				  correctional halfway house.
(20) "Credentialing" means a process of
				  review to determine the professional level at which an employee may
				  practice.
(21) "Crisis intervention
				  training" means training of staff to respond adequately to emergency
				  situations, including:
(a) Medical
				  emergencies;
(b) Emotional and
				  psychological crises; and
(c)
				  Emergencies arising from environmental circumstances such as fires, floods,
				  terrorism, and other disasters.
(22) Critical Incident.
(a) "Critical incident" means a life, safety,
				  or health threat involving the staff or patients participating in a
				  program.
(b) "Critical incident"
				  includes, but is not limited to, death or physical or sexual assault.
(23) "Critical incident report"
				  means the documentation of a critical incident.
(24) "Department" means the Department of
				  Health and Mental Hygiene.
(25)
				  "Detoxification" means the process of withdrawing addictive psychoactive
				  substances from the body in a safe and effective manner.
(26) "Director" means the Director of the
				  Administration.
(27) "Discharge
				  plan" means a written description of specific goals and objectives to assist
				  the patient upon leaving treatment.
(28) Dispense.
(a) "Dispense" means to deliver a controlled
				  dangerous substance or other drug to the ultimate user by a practitioner
				  pursuant to a lawful order of the practitioner.
(b) "Dispense" includes prescribing,
				  administering, packaging, labeling or compounding necessary to prepare the
				  substance for delivery.
(29) "Documentation" means written or
				  recorded information that is dated.
(30) "Drug" means:
(a) A controlled dangerous substance that is
				  regulated under the Maryland Controlled Dangerous Substances Act;
(b) A prescription medication; or
(c) A chemical substance when used for
				  unintended and harmful purposes.
(31) "Drug abuse" means a disease which is
				  characterized by a pattern of pathological use of a drug with repeated attempts
				  to control its use, and with significant negative consequences in at least one
				  of the following areas of life: medical, legal, financial, or
				  psychosocial.
(32) "Drug
				  dependence" means a disease characterized by:
(a) Drug abuse; and
(b) Physical symptoms of withdrawal or
				  tolerance.
(33) "Family"
				  means an individual's immediate relatives or significant others.
(34) "Family counseling" means a distinct
				  discipline that utilizes accepted family system theories and intervention
				  techniques.
(35) "Governing body"
				  means the organizational structure that is responsible for establishing policy,
				  maintaining quality care, and providing management and planning for the
				  program.
(36) "Individualized
				  treatment plan" means a written plan of action that is developed and modified
				  to address a patient's specific service needs.
(37) "Intermediate care facility" means a
				  facility that provides a planned regimen of 24-hour professionally directed
				  evaluation, observation, medical monitoring, and addiction treatment in an
				  inpatient setting.
(38)
				  "Maintenance" means medically supervised continuation of the administration of
				  methadone, LAAM, or other drugs approved by the Administration.
(39) "Medical director" means a physician who
				  oversees the medical practice of a program.
(40) "Methadone" means a synthetic
				  opioid.
(41) "Nurse" means an
				  individual who is licensed by the State Board of Nursing to practice registered
				  nursing or licensed practical nursing as defined in Health Occupations Article,
				  §
											8-101, Annotated
				  Code of Maryland.
(42) "Nurse
				  practitioner" means a registered nurse who is certified as a nurse practitioner
				  as defined in Health Occupations Article, §
											8-508, Annotated
				  Code of Maryland.
(43) "Office of
				  Health Care Quality" means the office under the Department that oversees
				  certification and inspection of programs for the Administration.
(44) "Patient" means an individual who is
				  admitted into a program.
(45)
				  "Physician" means any person authorized by law to practice medicine in this
				  State under Health Occupations Article, §
											14-101, Annotated
				  Code of Maryland.
(46) "Physician
				  assistant" means an individual licensed to act as an assistant to a licensed
				  physician in Maryland, as defined in Health Occupations Article, §
											15-101, Annotated
				  Code of Maryland.
(47) "Possess"
				  means the exercise of actual or constructive dominion or control over a
				  controlled dangerous substance.
(48) "Prevention program" means the Early
				  Intervention Level 0.5 level of treatment as described in COMAR
				  10.47.02.03B.
(49) "Privileging" means the
				  process of review to determine the duties a volunteer or employee may
				  perform.
(50) "Problem Oriented
				  Screening Instrument for Teenagers" means a standardized method of screening to
				  determine whether or not an adolescent may have alcohol or other drug abuse or
				  dependence or both and will need further evaluation.
(51) Program.
(a) "Program" means any organization or
				  individual that provides treatment, care, or rehabilitation for individuals who
				  show the effects of drug abuse or alcohol abuse, and represents or advertises
				  itself as an alcohol or other drug abuse treatment program.
(b) "Program" includes a:
(i) Program or facility that is owned or
				  operated by the State or any of its political subdivisions; and
(ii) Detoxification facility as defined in
				  Health-General Article, §8-101(g), Annotated Code of Maryland.
(52) "Progress note"
				  means an objective documentation of the patient's progress in relation to
				  specific treatment goals and objectives.
(53) "Screening" means the utilization of a
				  valid tool or instrument approved by the Administration to determine whether or
				  not an individual may have alcohol or other drug abuse or dependence or both
				  and will need further evaluation.
(54) "Secretary" means the Secretary of
				  Health and Mental Hygiene.
(55)
				  "Self-help group" means a voluntary fellowship or group that supports patients
				  in recovery from alcohol and other drug abuse or dependence.
(56) "Therapeutic agent" means an
				  intervention that is used to effect positive change.
(57) "Treatment plan goal" means an intended
				  resolution of a patient's clinical condition or problem that is completed
				  within a specific amount of time and will contribute to the completion of
				  treatment in a program.
(58)
				  "Treatment plan objective" means a behaviorally measurable symptom or social,
				  legal, or family change that results in a stepwise achievement of a treatment
				  goal.
(59) "Utilization review"
				  means a systematic assessment of the appropriateness of patient admissions,
				  continuation in treatment, and referral to specific treatment services within a
				  program.
(60) "Variance" means an
				  alternate method of meeting the intent of a regulation under this
				  subtitle.
(61) "Waiting list" means
				  a list of individuals who are appropriate for services from a program but for
				  whom a treatment slot is not available for 4 or more weeks for outpatient
				  programs, or 2 or more weeks for residential programs.
(62) "Waiver" means the exemption from
				  compliance with a regulation under this subtitle.